Edesa Biotech, Inc. Quarterly Debt-to-equity in % from Q2 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Edesa Biotech, Inc. quarterly Debt-to-equity history and growth rate from Q2 2015 to Q2 2024.
  • Edesa Biotech, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 41.5 %, a 122% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 41.5 +22.8 +122% Jun 30, 2024
Q1 2024 30.1 +3.04 +11.2% Mar 31, 2024
Q4 2023 23.8 -2.34 -8.96% Dec 31, 2023
Q3 2023 19 -7.79 -29.1% Sep 30, 2023
Q2 2023 18.7 -4.95 -20.9% Jun 30, 2023
Q1 2023 27.1 +13.3 +96.4% Mar 31, 2023
Q4 2022 26.1 +10.6 +68% Dec 31, 2022
Q3 2022 26.8 +11.9 +79.4% Sep 30, 2022
Q2 2022 23.7 +6.53 +38.1% Jun 30, 2022
Q1 2022 13.8 -8.04 -36.8% Mar 31, 2022
Q4 2021 15.6 -1.3 -7.72% Dec 31, 2021
Q3 2021 14.9 -3.8 -20.3% Sep 30, 2021
Q2 2021 17.1 +2.68 +18.6% Jun 30, 2021
Q1 2021 21.8 Mar 31, 2021
Q4 2020 16.8 Dec 31, 2020
Q3 2020 18.7 Sep 30, 2020
Q2 2020 14.4 Jun 30, 2020
Q3 2015 31.6 Sep 30, 2015
Q2 2015 34.8 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.